TORRANCE, Calif., Jan. 25, 2021 /PRNewswire/ — Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in the treatment of sickle cell disease, reported today its financial results for the year ended December 31, 2019 and its restated financial